Compremium Receives FDA Breakthrough Device Designation for Non-Invasive Central Venous Pressure Measurement System and has also joined FDA’s TAP Progr…

Compremium AG today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ...
Business Wire

Global Central Venous Catheters Market Research 2021-2025 | COVID-19 Industry Planning Structure | Technavio

LONDON--(BUSINESS WIRE)--The central venous catheters market is poised to grow by USD 138.10 million during 2021-2025, progressing at a CAGR of almost 3% during the forecast period. Worried about the ...
Business Wire

Global Central Venous Catheters (CVCs) Strategic Market Report 2023: Developing Economies to Spearhead Long-term Growth - Forecast to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Central Venous Catheters (CVCs) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global Central Venous Catheters (CVCs) Market to ...
Nature

Central Venous Catheterization and Guidewire Management

Central venous catheterization is a critical procedure routinely employed to deliver medications, fluids, and for haemodynamic monitoring in hospital settings. The technique, commonly executed using ...
Morningstar

InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions

InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions Recana Thrombectomy Catheter System is ...